Sanofi news：Sanofi CEO under pressure to woo investors after ...
Sanofi CEO under pressure to woo investors after ...
4天前—Sanofi'sCEOisunderpressuretotellinvestorshowmuchmorehewillspendonresearchanddevelopment(R&D)andwhatthelikelypay-offs ...。其他文章還包含有：「Media」、「PressRelease」、「PressRelease」、「PressReleases」、「Pressreleases2022」、「Pressreleases2023」、「SanofiCEOPaulHudsononR&DDay」、「Sanofihailsdrughopefulsinwakeofstockslump」、「Sanofi」
查看更多 離開網站
Media
https://www.sanofi.com
View the latest press releases and media resources from the global healthcare and pharmaceutical company Sanofi.
Press Release
https://www.sanofi.com
Press Release: Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to ...
Press Release
https://www.sanofi.com
Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed multiple myeloma not ...
Press Releases
https://www.sanofi.com
Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to ...
Press releases 2022
https://www.sanofi.com
View the press releases published in 2022 from Sanofi global pharmaceutical and healthcare company.
Press releases 2023
https://www.sanofi.com
Press Release: TZIELD® Phase 3 data presented at ISPAD shows potential to slow the progression of Stage 3 type 1 diabetes in newly diagnosed children and ...
Sanofi CEO Paul Hudson on R&D Day
https://www.youtube.com
Sanofi hails drug hopefuls in wake of stock slump
https://www.reuters.com
Sanofi vaunted 12 drugs in development with the potential to make more than $1 billion in annual sales, but failed to reverse a recent ...
Sanofi
https://www.sanofi.com
Our latest news. December 6, 2023. Press Release: Sarclisa® (isatuximab) Phase 3 ... Press Release: Sanofi's Consumer Healthcare unit launches the Shared Care ...